Compare ThredUp Inc (TDUP) vs UnitedHealth Group Inc (UNH) Price & Performance

ThredUp (TDUP) trades at $3.17, up 0.96% on the day, but remains under pressure after a significant Q2 2026 earnings miss and lowered full-year revenue guidance. The stock's technical picture is bearish, while fundamentals show improving revenue growth but persistent losses. Recent news highlights an ongoing securities investigation related to the guidance revision, contributing to negative sentiment.

The outlook is cautious. While analyst consensus is technically 'Buy' (57% of ratings), recent operational setbacks and the stock's sharp decline post-earnings suggest significant near-term risk. The primary opportunity lies in the company's high gross margins and active buyer growth, but profitability remains elusive and investor confidence is fragile.

UnitedHealth Group (UNH) trades at $399.06, down 0.78% on the day, with a bearish technical signal but strong fundamental support from consistent earnings beats. The company reported Q2 2026 EPS of $6.38, beating expectations of $4.94, and maintains robust cash flow, funding dividends and buybacks. Recent news highlights strategic moves to reduce pediatric prior authorizations, aiming to improve care access and operational efficiency.

Outlook remains positive with an analyst consensus price target of $476.50, implying 19% upside, though regulatory risks from lawsuits and Medicaid fraud allegations pose challenges. The stock's valuation at a P/E of 26.07 is justified by its market leadership and growth in aging demographics, but investors should monitor legal developments and margin pressures.